查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1533590

次世代定序市場規模、佔有率和成長分析：按產品/服務、技術、最終用戶、地區分類 - 產業預測，2024-2031 年

Next Generation Sequencing Market Size, Share, Growth Analysis, By Product & Service, By Technology, By End User, By Region - Industry Forecast 2024-2031
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球次世代定序市場規模將為78.2億美元，從2023年的92.7億美元成長到2031年的360.4億美元，預計到2031年（2024年~2031年）將達到360.4億美元。成長率為18.5%。

次世代定序(NGS) 是一項先進技術，利用大規模並行性同時對數百萬至數十億條 DNA 鏈進行定序。 NGS，有時也稱為高通量定序，與傳統的桑格定序方法相比具有顯著的優勢。與依賴片段克隆策略的桑格定序不同，NGS具有成本效益高、準確度高、快速出結果的特性。即使使用最小的樣品量也可以獲得準確的結果。因此，NGS 已成為多個領域的重要工具，包括生物標記發現、癌症研究、個人化醫療、農業和動物測試。基因組定序的應用也擴展到了解 COVID-19 等疾病的傳播。英國 COVID-19 基因組聯盟 (COG-UK) 成立於 2020 年 3 月，利用全基因組定序來探索冠狀病毒基因組。該聯盟包括 Wellcome Sanger Institute、NHS、公共衛生機構和多個學術機構之間的合作。這些組織的共同努力旨在繪製病毒的進化和傳播模式，並提高我們對干預措施如何影響疾病進展和治療策略的理解。

目錄

介紹

  • 研究目的
  • 定義
  • 市場範圍

調查方法

  • 資訊採購
  • 次要/一級資訊來源
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 市場概況展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及展望

  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
  • 波特的分析

主要市場考察

  • 技術分析
  • 價格分析
  • 價值鏈分析
  • 市場生態系統
  • Start-Ups分析
  • 專利分析
  • 客戶和購買標準分析
  • 監管環境
  • 創新矩陣
  • 重點投資分析
  • 關鍵成功因素
  • 市場魅力指數
  • 競爭程度

次世代定序市場：依產品/服務分類

  • 市場概況
  • NGS耗材
  • 定序服務
    • EXOME靶向定序和自訂面板
    • RNA定序
    • 從頭定序
    • 晶片定序
    • 全基因組序列分析
    • 甲基序列
    • 其他定序服務
  • 預測序產品和服務
    • 文庫製備/靶向序列捕獲
    • 品管
  • NGS平台
    • 照明公司
    • NovaSeq系統
    • 下一代定序系統
    • 米定序系統
    • iSeq 100 系統
    • MiniSeq系統
    • 熱漁科學
    • 牛津奈米孔技術
    • 太平洋生物科學公司
    • 其他NGS平台
  • 生物資訊學
    • NGS資料分析服務
    • NGS資料分析軟體和工作台
    • NGS儲存、管理和雲端運算解決方案
  • NGS 平台服務

次世代定序市場：依技術分類

  • 市場概況
  • 合成定序
  • 離子半導體定序
  • 奈米孔定序
  • 單分子即時定序
  • 其他定序技術

次世代定序市場：依應用分類

  • 市場概況
  • 診斷
    • 癌症診斷
    • 感染疾病診斷
    • 生殖健康檢查
    • 其他診斷應用
  • 藥物發現與開發
    • 藥物基因組學
    • 其他藥物發現與開發應用
  • 農業和動物研究
  • 其他用途

次世代定序市場：依最終用戶分類

  • 市場概況
  • 學術機構/研究中心
  • 製藥和生物技術公司
  • 醫院/診所
  • 參考實驗室
  • 其他最終用戶

次世代定序市場規模：按地區分類

  • 市場概況
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲 (MEA)
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲地區

競爭格局

  • 前5名企業對比
  • 主要企業市場定位（2023年）
  • 主要市場參與者所採取的策略
  • 近期市集活動
  • 主要企業市場佔有率（2023年）

主要企業簡介

  • Illumina Inc.（US）
  • Thermo Fisher Scientific Inc.（US）
  • PerkinElmer Inc.（US）
  • BGI Group（China）
  • Agilent Technologies Inc.（US）
  • Eurofins Scientific SE（Luxembourg）
  • Pacific Biosciences of California Inc.（US）
  • Oxford Nanopore Technologies（UK）
  • QIAGEN NV（Netherlands）
  • F. Hoffmann-La Roche AG（Switzerland）
  • GENEWIZ Inc.（US）
  • Psomagen, Inc.（South Korea）
  • 10x Genomics Inc.（US）
  • Takara Bio（Japan）
  • Zymo Research（US）
  • NuGen Technologies（US）
  • Hamilton Company（US）
  • Beckman Coulter（US）
  • Becton, Dickinson, and Company（US）
  • Lucigen Corporation（US）
  • Novogene Co., Ltd.（China）
簡介目錄
Product Code: SQMIG35D2046

Global Next Generation Sequencing Market size was valued at USD 7.82 billion in 2022 and is poised to grow from USD 9.27 billion in 2023 to USD 36.04 billion by 2031, growing at a CAGR of 18.5% in the forecast period (2024-2031).

Next-generation sequencing (NGS) is an advanced technique that utilizes massive parallelism to sequence millions or even billions of DNA strands simultaneously. Often referred to as high-throughput sequencing, NGS offers significant advantages over traditional Sanger sequencing methods. Unlike Sanger sequencing, which relies on fragment-cloning strategies, NGS is characterized by its cost-effectiveness, high accuracy, and rapid results. It is capable of delivering precise outcomes even with minimal sample quantities. As a result, NGS has become a critical tool in various fields, including biomarker discovery, cancer research, personalized medicine, agriculture, and animal studies. The application of genome sequencing extends to understanding the spread of diseases such as COVID-19. The COVID-19 Genomics U.K. Consortium (COG-U.K.), established in March 2020, utilizes whole-genome sequencing to explore the coronavirus genome. This consortium includes collaborations between the Wellcome Sanger Institute, the NHS, public health agencies, and several academic institutions. The collective efforts of these organizations aim to map the virus's evolution and transmission patterns, enhancing our understanding of how interventions impact disease progression and treatment strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Next Generation Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Next Generation Sequencing Market Segmental Analysis

The next generation sequencing market is segmented into Product and Service, Technology, Application, End User and region. Based on the Product & Service, the market is segmented into NGS Consumables, Sequencing Services (Exome & Targeted Resequencing and Custom Panels, RNA Sequencing, DE NOVO Sequencing, Chip Sequencing, Whole-genome sequencing, MethYl Sequencing, Other Sequencing Services), Pre-sequencing Products & Services (Library Preparation And Target Enrichment, Quality Control), NGS Platforms (Illumina [NovaSeq Systems, Nextseq Systems, Miseq Systems, iSeq 100 Systems, Miniseq Systems], Thermo Fisher Scientific, Oxford Nanopore Technologies, Pacific Biosciences, Other NGS Platforms), Bioinformatics (NGS Data Analysis Services, NGS Data Analysis Software and Workbenches, NGS Storage, Management, And Cloud Computing Solutions), Services for NGS Platforms. Based on the Technology, the market is segmented into Sequencing by Synthesis, Ion Semiconductor Sequencing, Nanopore Sequencing, Single-molecule Real-time Sequencing, and Other Sequencing Technologies. Based on Application, the market is segmented into Diagnostics (Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Other Diagnostic Applications, Drug Discovery and Development (Pharmacogenomics, Other Drug Discovery and Development Applications), Agricultural and Animal Research, Other Applications. Based on the End-user, the market is segmented into Academic Institutes and Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Reference Laboratories, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia-Pacific, South America, and Middle East and Africa.

Drivers of the Global Next Generation Sequencing Market

The development of new and innovative technologies has led to the rise of next-generation sequencing (NGS), which is characterized by its speed, portability, and user-friendliness. These advancements enable quicker and more precise analyses, with significantly reduced turnaround times. By leveraging these technological improvements, companies gain a competitive edge, leading to increased investments in research and development. This, in turn, drives market growth and enhances the overall investment in innovation. The introduction of NGS represents a major leap forward in sequencing technology, offering substantial benefits in terms of efficiency and accuracy. These enhancements facilitate more rapid and reliable data analysis, positioning firms at the forefront of the industry. As businesses capitalize on these advancements, they contribute to a surge in market activity and foster further innovation, reinforcing their market position and driving continued growth in the sector.

Restraints in the Global Next Generation Sequencing Market

Next-generation sequencing generates enormous volumes of data, leading to significant challenges related to data storage, management, and analysis. The sheer scale of data produced necessitates the use of advanced and specialized bioinformatics tools and expertise, which may not always be readily available within an organization. These requirements can affect research and development timelines, elevate operational costs throughout the development cycle, and potentially restrict market opportunities. As a result, organizations may face difficulties in efficiently handling and leveraging the vast amounts of data generated by NGS technologies.

Market Trends of the Global Next Generation Sequencing Market

Next-generation sequencing (NGS) is increasingly utilized in both high and low-throughput research due to its growing simplicity, decreasing costs, and enhanced bioinformatics support. The application of NGS-based testing systems is broadening across various clinical fields, including oncology, reproductive health, and genetics. Organizations and companies are continuously striving for improvements and advancements in NGS technologies. For instance, RNA-sequencing is evolving to address a wider array of scientific and clinical domains, reflecting the ongoing efforts to expand the capabilities and applications of NGS.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • Start-up Analysis
  • Patent Analysis
  • Customer & Buying Criteria Analysis
  • Regulatory Landscape
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Market Attractive Index
  • Degree of Competition

Next Generation Sequencing Market by Product & Service

  • Market Overview
  • NGS Consumables
  • Sequencing Services
    • Exome & Targeted Resequencing and Custom Panels
    • RNA Sequencing
    • DE NOVO Sequencing
    • Chip sequencing
    • Whole-genome sequencing
    • Methyl sequencing
    • Other sequencing services
  • Pre-Sequencing Products & Services
    • Library preparation and target enrichment
    • Quality control
  • NGS Platforms
    • Illumina
    • NovaSeq systems
    • NextSeq systems
    • MiSeq systems
    • iSeq 100 systems
    • MiniSeq systems
    • Thermo Fisher Scientific
    • Oxford Nanopore Technologies
    • Pacific Biosciences
    • Other NGS Platforms
  • Bioinformatics
    • NGS Data Analysis Services
    • NGS Data Analysis Software and Workbenches
    • NGS Storage, Management, And Cloud Computing Solutions
  • Services for NGS Platforms

Next Generation Sequencing Market by Technology

  • Market Overview
  • Sequencing by synthesis
  • Ion semiconductor sequencing
  • Nanopore sequencing
  • Single-molecule real-time sequencing
  • Other sequencing technologies

Next Generation Sequencing Market by Application

  • Market Overview
  • Diagnostics
    • Cancer diagnostics
    • Infectious disease diagnostics
    • Reproductive health diagnostics
    • Other diagnostic applications
  • Drug discovery and development
    • Pharmacogenomics
    • Other drug discovery and development applications
  • Agricultural and animal research
  • Other applications

Next Generation Sequencing Market by End user

  • Market Overview
  • Academic institutes and research centers
  • Pharmaceutical and biotechnology companies
  • Hospitals and clinics
  • Reference laboratories
  • Other end users

Next Generation Sequencing Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Illumina Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BGI Group (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific SE (Luxembourg)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pacific Biosciences of California Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxford Nanopore Technologies (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN NV (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GENEWIZ Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Psomagen, Inc. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 10x Genomics Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zymo Research (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NuGen Technologies (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hamilton Company (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beckman Coulter (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson, and Company (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lucigen Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novogene Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments